Sio Gene Therapies Inc. (SIOX) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 9 transactions totaling $271.4K, demonstrating a bullish sentiment with $271.4K in net insider flow. The most recent transaction on Dec 8, 2021 involved a transaction of 14,884 shares valued at $21.1K.
No significant insider buying has been recorded for SIOX in the recent period.
No significant insider selling has been recorded for SIOX in the recent period.
Based on recent SEC filings, insider sentiment for SIOX is bullish with an Insider Alignment Score of 100/100 and a net flow of $271.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Sio Gene Therapies Inc. (SIOX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading SIOX stock, having executed 9 transactions in the past 90 days. The most active insider is Pavan Cheruvu (Executive), who has made 4 transactions totaling $269.1K.
Get notified when executives and directors at SIOX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 8, 2021 | Cheruvu Pavan | Executive | Payment | 14,884 | $1.42 | $21.1K | |
| Dec 8, 2021 | Cheruvu Pavan | Executive | Award | 37,567 | $N/A | $0 | |
| Dec 8, 2021 | W. Nassif David | Executive | Payment | 6,294 | $1.42 | $8.9K | |
| Dec 8, 2021 | W. Nassif David | Executive | Award | 17,534 | $N/A | $0 | |
| Mar 23, 2021 | Cheruvu Pavan | Executive | Purchase | 100,000 | $2.48 | $248.0K | |
| Mar 22, 2021 | W. Nassif David | Executive | Award | 15,060 | $N/A | $0 | |
| Mar 17, 2021 | Cheruvu Pavan | Executive | Award | 22,590 | $N/A | $0 | |
| Mar 17, 2021 | Corcoran Gavin | Executive | Award | 16,001 | $N/A | $0 | |
| Nov 24, 2020 | Pande Atul | Executive | Purchase | 10,000 | $2.34 | $23.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 2 | $271.4K | 90.0% |
Payment(F) | 2 | $30.1K | 10.0% |
Award(A) | 5 | $0 | 0.0% |
Insiders at Sio Gene Therapies Inc. are accumulating shares at an accelerated pace. With 4 insiders making 9 transactions totaling $271.4K in purchases versus $0 in sales, the net buying activity of $271.4K signals strong executive confidence. Pavan Cheruvu (Executive) leads the buying activity with $269.1K in transactions across all time.